Drawing for CLINISTIX

USPTO serial 97978648

CLINISTIX

Reviewed by CopyMark Law Group

Reg. 7560751Status 700Registered
Filing date
Status date
Registration date
Nov 5, 2024
Examiner
BROWN, BARBARA TROFFKIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CLINISTIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew Chien

511 BENEDICT AVE.SIEMENS HEALTHCARE DIAGNOSTICS INC.TARRYTOWN, NY 10591

Goods and services

ClassDescriptionStatusFirst use
005medical diagnostic reagents for the analysis of body fluidsACTIVEMay 28, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 5, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 12, 2024ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Sep 12, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 12, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 14, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 14, 2024DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 14, 2024DRRRDIVISIONAL REQUEST RECEIVED—
Aug 5, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 18, 2024IUAFUSE AMENDMENT FILED—
Jun 18, 2024ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jun 18, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 9, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 8, 2024EX1GSOU EXTENSION 1 GRANTED—
Feb 8, 2024EXT1SOU EXTENSION 1 FILED—
Feb 8, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 19, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 25, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 25, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 5, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 21, 2023PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 13, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 17, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 17, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 26, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 26, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 26, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2022DOCKASSIGNED TO EXAMINER—
Mar 22, 2022AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 22, 2022ALIEASSIGNED TO LIE—
Mar 18, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 18, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 17, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance